Newsroom - Page 13

Minnesota's attorney general helped resolve a split that was a sign of the times. Top-performing hospitals increasingly find themselves on the outside of narrow networks when managed care contracts try to limit costs.
The FDA has placed 3 clinical trials of Keytruda (pembrolizumab) on hold in response to a pattern of patient deaths, according to a statement from Merck.
Coverage of our peer-reviewed research in the healthcare and mainstream press.
There is limited evidence connecting depression to the disease course of inflammatory bowel disease, according to a new study. However, Crohn's disease had a strong association.
The BreathLink device is intended to immediately identify any indications of breast cancer based on a 2-minute sample of a patient’s breath.
As more practices adopt the COME HOME model, they are adapting it to fit their needs, explained Barbara McAneny, MD, chief medical officer of New Mexico Oncology Hematology Consultants. However, some practices may not have the resources to keep up with data collection requirements while ramping up clinical interventions.
Biosimilar molecules have gained access to the US market, and providers and patients are steadily warming up to the idea of using these products, but challenges still exist. Here are 5 of the recent developments in the biosimilar landscape.
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST